Insider trading · Q3 2026 · CIK 925741

BioCardia, Inc. (BCDA) insider trading.

In Q3 2026, insiders at BioCardia, Inc. reported 19 non-derivative transactions on 22 Forms 3, 4 and 5: 13 open-market purchases worth $31K and 0 sales.

Transactions
19
Purchases (P)
13
Sales (S)
0
Net shares, P minus S
33,700
Insiders
3
Last filed
2026-09-30

Insiders

InsiderRelationshipTransactionsBuysSales
Altman PeterDirector, Officer · President and CEO15130
Gillis Edward MOfficer · Senior Vice President, Devices200
McClung DavidOfficer · Chief Financial Officer200

Transactions

19 non-derivative rows, newest transaction first. Shares and prices as filed.
DateInsiderCodeSharesPriceOwned afterFiling
2026-09-29Altman PeterP (A)1,000$1.03384,885Form 4
2026-09-23Altman PeterP (A)1,900$1.05383,885Form 4
2026-09-03Altman PeterP (A)800$1.09381,985Form 4
2026-08-17Altman PeterP (A)5,400$0.93381,115Form 4
2026-08-13Altman PeterP (A)1,900$0.92375,785Form 4
2026-07-29Altman PeterP (A)5,000$0.78373,885Form 4
2026-07-17Altman PeterP (A)500$0.83368,885Form 4
2026-07-15Altman PeterP (A)1,500$0.86368,385Form 4
2026-07-14Altman PeterP (A)2,800$0.88366,885Form 4
2026-07-10Altman PeterP (A)1,000$0.94369,485Form 4
2026-07-09Altman PeterP (A)1,000$0.9368,485Form 4
2026-07-08Altman PeterP (A)5,500$0.97367,485Form 4
2026-07-08Altman PeterP (A)5,400$0.96361,985Form 4
2026-07-02Gillis Edward MF (D)17,269$1.2454,126Form 4
2026-07-02McClung DavidF (D)23,125$1.24114,245Form 4
2026-07-02Altman PeterF (D)54,606$1.24356,585Form 4
2026-06-29Gillis Edward MA (A)39,521$1.271,395Form 4
2026-06-29McClung DavidA (A)60,483$1.2137,370Form 4
2026-06-29Altman PeterA (A)110,625$1.2411,191Form 4

Transaction codes in this quarter

Get BCDA insider transactions through the API

Request with your API key
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=925741&limit=100" \
  -H "Authorization: Bearer $SEC_API_KEY"

Insider trading API guide · BCDA company page · BioCardia, Inc. on SEC.gov

Questions

Are insiders buying or selling BioCardia, Inc. (BCDA)?

In Q3 2026, insiders at BioCardia, Inc. reported 19 non-derivative transactions on 22 Forms 3, 4 and 5: 13 open-market purchases worth $31K and 0 sales. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.

Where do these BioCardia, Inc. insider trades come from?

From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.

Source: SEC Insider Transactions Data Sets, Q3 2026, retrieved 2026-10-27. Footnotes, derivative holdings and amendments are in the linked filings. Not investment advice.

Plain-text version for agents and LLMs: /insider-trading/bcda.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.